Literature DB >> 23873032

Clinical characteristics of papillary thyroid microcarcinoma less than or equal to 5 mm on ultrasonography.

Hyoung Shin Lee1, Hyo Sang Park, Sung Won Kim, Gwan Choi, Hun-Su Park, Jong-Chul Hong, Sung-Geun Lee, Seon Mi Baek, Kang Dae Lee.   

Abstract

Management of papillary thyroid microcarcinoma sized ≤5 mm identified on ultrasonography is controversial. In this study, we evaluated the clinical characteristics of papillary thyroid microcarcinoma sized ≤5 mm on ultrasonography in comparison to those >5 mm and sought to present rationales for optimal management in papillary thyroid microcarcinoma ≤5 mm. The medical records of 396 patients who underwent surgery for papillary thyroid carcinoma between 2009 and 2011 were retrospectively analyzed. The patients were grouped into A (≤5 mm, n = 132) or B (>5 mm, n = 264) and the clinicopathologic characteristics of the patients were reviewed and compared between the two groups. Tumor capsular invasion (45.5 vs. 59.8 %, p = 0.007) and cervical lymph node metastasis (18.2 vs. 29.2 %, p = 0.018) were more frequent in group B. Nonetheless, group A presented lymph node metastasis in 42.3 % of multifocal cases showing no difference to that of group B (41.5 %, p = 0.946) and also included five cases (3.8 %) of lateral neck metastasis. Multifocality was the only predictive factor for lymph node metastasis in group A (p < 0.001). Over half (55.3 %) of the patients of group A were diagnosed with papillary carcinoma in private clinics; however, only 5.5 % of these patients underwent assessment of lateral neck lymph nodes initially. In conclusion, higher risk of cervical lymph node metastasis should be considered in evaluation and surgical decision of papillary thyroid microcarcinoma ≤5 mm identified on ultrasonography with multifocality. Evaluation of the cervical lymph nodes including the lateral neck should not be overlooked when suspicious thyroid nodule suggesting malignancy sized ≤5 mm shows multifocal lesions.

Entities:  

Mesh:

Year:  2013        PMID: 23873032     DOI: 10.1007/s00405-013-2634-6

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  25 in total

1.  Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: a study of 1066 patients.

Authors:  Ling Zhang; Wen-Jun Wei; Qing-Hai Ji; Yong-Xue Zhu; Zhuo-Ying Wang; Yu Wang; Cai-Ping Huang; Qiang Shen; Duan-Shu Li; Yi Wu
Journal:  J Clin Endocrinol Metab       Date:  2012-02-08       Impact factor: 5.958

2.  'Aggressive papillary' thyroid microcarcinoma.

Authors:  Cyril Page; Aurélie Biet; Pierrick Boute; Philippe Cuvelier; Vladimir Strunski
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-03-18       Impact factor: 2.503

3.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Bryan R Hauger; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Furio Pacini; Martin Schlumberger; Steven I Sherman; David L Steward; R Michael Tuttle
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

4.  Cervical lymph node metastasis and papillary thyroid carcinoma: does the compartment involved affect survival? Experience from the SEER database.

Authors:  Valerie A Smith; Roy B Sessions; Eric J Lentsch
Journal:  J Surg Oncol       Date:  2012-03-05       Impact factor: 3.454

5.  An observational trial for papillary thyroid microcarcinoma in Japanese patients.

Authors:  Yasuhiro Ito; Akira Miyauchi; Hiroyuki Inoue; Mitsuhiro Fukushima; Minoru Kihara; Takuya Higashiyama; Chisato Tomoda; Yuuki Takamura; Kaoru Kobayashi; Akihiro Miya
Journal:  World J Surg       Date:  2010-01       Impact factor: 3.352

6.  Preoperative prediction of central lymph node metastasis in thyroid papillary microcarcinoma using clinicopathologic and sonographic features.

Authors:  Kyung-Eun Kim; Eun-Kyung Kim; Jung Hyun Yoon; Kyung Hwa Han; Hee Jung Moon; Jin Young Kwak
Journal:  World J Surg       Date:  2013-02       Impact factor: 3.352

7.  New subgrouping of small thyroid carcinomas.

Authors:  N Kasai; A Sakamoto
Journal:  Cancer       Date:  1987-10-15       Impact factor: 6.860

Review 8.  Lateral lymph node dissection guided by preoperative and intraoperative findings in differentiated thyroid carcinoma.

Authors:  Yasuhiro Ito; Akira Miyauchi
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

9.  Predictive factors for central compartment lymph node metastasis in thyroid papillary microcarcinoma.

Authors:  Sang-Hyuk Lee; Seung-Suk Lee; Sung-Min Jin; Jin-Hwan Kim; Young-Soo Rho
Journal:  Laryngoscope       Date:  2008-04       Impact factor: 3.325

10.  Risk factors contributing to a poor prognosis of papillary thyroid carcinoma: validity of UICC/AJCC TNM classification and stage grouping.

Authors:  Yasuhiro Ito; Akira Miyauchi; Tomoo Jikuzono; Takuya Higashiyama; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka; Kiyoshi Ichihara; Kanji Kuma
Journal:  World J Surg       Date:  2007-04       Impact factor: 3.352

View more
  12 in total

1.  Hashimoto's Thyroiditis Does Not Affect Ultrasonographical, Cytological, and Histopathological Features in Patients with Papillary Thyroid Carcinoma.

Authors:  Husniye Baser; Didem Ozdemir; Neslihan Cuhaci; Cevdet Aydin; Reyhan Ersoy; Aydan Kilicarslan; Bekir Cakir
Journal:  Endocr Pathol       Date:  2015-12       Impact factor: 3.943

2.  Papillary thyroid carcinoma with exclusive involvement of a functioning recurrent laryngeal nerve may be treated using a shaving technique: reply.

Authors:  Hyoung Shin Lee; Sung Won Kim; Jong Chul Hong; Kang Dae Lee
Journal:  World J Surg       Date:  2015-07       Impact factor: 3.352

Review 3.  Risk Factors for Central Compartment Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Meta-Analysis.

Authors:  Ning Qu; Ling Zhang; Qing-Hai Ji; Jia-Ying Chen; Yong-Xue Zhu; Yi-Ming Cao; Qiang Shen
Journal:  World J Surg       Date:  2015-10       Impact factor: 3.352

4.  Ultrasonographic risk factors of malignancy in thyroid nodules.

Authors:  A Rios; B Torregrosa; J M Rodríguez; D Rodríguez; A Cepero; M D Abellán; N M Torregrosa; A M Hernández; P Parrilla
Journal:  Langenbecks Arch Surg       Date:  2016-06-04       Impact factor: 3.445

5.  [Radiomics for prediction of central lymph node metastasis in the neck in patients with thyroid papillary carcinoma].

Authors:  Weizhen Wang; Yingjia Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-09-30

6.  Acoustic radiation force impulse imaging: a new tool for the diagnosis of papillary thyroid microcarcinoma.

Authors:  Yi-Feng Zhang; Chang Liu; Hui-Xiong Xu; Jun-Mei Xu; Jing Zhang; Le-Hang Guo; Shu-Guang Zheng; Lin-Na Liu; Xiao-Hong Xu
Journal:  Biomed Res Int       Date:  2014-06-22       Impact factor: 3.411

7.  Ultrasonic features of papillary thyroid microcarcinoma and non-microcarcinoma.

Authors:  Xiao-Li Zhang; Lin-Xue Qian
Journal:  Exp Ther Med       Date:  2014-08-18       Impact factor: 2.447

Review 8.  How sensitive (second-generation) thyroglobulin measurement is changing paradigms for monitoring patients with differentiated thyroid cancer, in the absence or presence of thyroglobulin autoantibodies.

Authors:  Carole Spencer; Jonathan LoPresti; Shireen Fatemi
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-10       Impact factor: 3.243

9.  Clinicopathological features for predicting central and lateral lymph node metastasis in papillary thyroid microcarcinoma: Analysis of 66 cases that underwent central and lateral lymph node dissection.

Authors:  Yang Tao; Chongjie Wang; Liye Li; Haijun Xing; Yun Bai; Bing Han; Zhiyan Liu; Xiangshan Yang; Shourong Zhu
Journal:  Mol Clin Oncol       Date:  2016-11-18

10.  Sonographic and Clinical Features of Papillary Thyroid Microcarcinoma Less than or Equal to Five Millimeters: A Retrospective Study.

Authors:  Xingjian Lai; Bo Zhang; Yuxin Jiang; Jianchu Li; Ruina Zhao; Xiao Yang; Xiaoyan Zhang; Shenling Zhu; Qiong Wu; Sheng Cai; Yixiu Zhang
Journal:  PLoS One       Date:  2016-02-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.